Robert B Bazemore - Net Worth and Insider Trading

Robert B Bazemore Net Worth

The estimated net worth of Robert B Bazemore is at least $501,435 dollars as of 2024-11-13. Robert B Bazemore is the President & CEO of Epizyme Inc and owns about 322,626 shares of Epizyme Inc (EPZM) stock worth over $474,260. Robert B Bazemore is also the Director of Nuvation Bio Inc and owns about 5,000 shares of Nuvation Bio Inc (NUVB) stock worth over $27,175. Details can be seen in Robert B Bazemore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert B Bazemore has not made any transactions after 2021-03-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert B Bazemore

To

Robert B Bazemore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert B Bazemore owns 4 companies in total, including Epizyme Inc (EPZM) , Ardelyx Inc (ARDX) , and Neon Therapeutics Inc (NTGN) among others .

Click here to see the complete history of Robert B Bazemore’s form 4 insider trades.

Insider Ownership Summary of Robert B Bazemore

Ticker Comapny Transaction Date Type of Owner
EPZM Epizyme Inc 2021-03-25 director & President & CEO
ARDX Ardelyx Inc 2016-06-02 director
NTGN Neon Therapeutics Inc 2020-05-06 director
LIMIT LIMIT 2021-02-10 director

Robert B Bazemore Latest Holdings Summary

Robert B Bazemore currently owns a total of 2 stocks. Among these stocks, Robert B Bazemore owns 322,626 shares of Epizyme Inc (EPZM) as of March 25, 2021, with a value of $474,260 and a weighting of 94.58%. Robert B Bazemore also owns 5,000 shares of Nuvation Bio Inc (NUVB) as of March 30, 2021, with a value of $27,175 and a weighting of 5.42%.

Latest Holdings of Robert B Bazemore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EPZM Epizyme Inc 2021-03-25 322,626 1.47 474,260
NUVB Nuvation Bio Inc 2021-03-30 5,000 5.44 27,175

Holding Weightings of Robert B Bazemore


Robert B Bazemore Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert B Bazemore has made a total of 7 transactions in Epizyme Inc (EPZM) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Epizyme Inc is the sale of 10,328 shares on March 25, 2021, which brought Robert B Bazemore around $81,075.

According to the SEC Form 4 filings, Robert B Bazemore has made a total of 1 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Nuvation Bio Inc is the acquisition of 5,000 shares on March 30, 2021, which cost Robert B Bazemore around $49,900.

Insider Trading History of Robert B Bazemore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert B Bazemore Trading Performance

GuruFocus tracks the stock performance after each of Robert B Bazemore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert B Bazemore is -8.99%. GuruFocus also compares Robert B Bazemore's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert B Bazemore within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert B Bazemore's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert B Bazemore

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.38 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.76 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert B Bazemore Ownership Network

Ownership Network List of Robert B Bazemore

No Data

Ownership Network Relation of Robert B Bazemore

Insider Network Chart

Robert B Bazemore Owned Company Details

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Robert B Bazemore is the director & President & CEO of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Epizyme Inc Insider Transactions

No Available Data

Robert B Bazemore Mailing Address

Above is the net worth, insider trading, and ownership report for Robert B Bazemore. You might contact Robert B Bazemore via mailing address: 33 Hayden Ave, Lexington Ma 02421.